Previous close | 4.2700 |
Open | 6.3600 |
Bid | 1.9500 |
Ask | 6.4000 |
Strike | 775.00 |
Expiry date | 2024-06-21 |
Day's range | 4.2700 - 6.3600 |
Contract range | N/A |
Volume | |
Open interest | 4 |
First Quarter Results Show Revenue Decline but Strong Dupixent and Libtayo Sales Growth
It is hard to get excited after looking at Regeneron Pharmaceuticals' (NASDAQ:REGN) recent performance, when its stock...
Regeneron Pharmaceuticals earnings and sales missed first-quarter estimates early Thursday. Shares fell slightly.